Experienced in Hyperkalemic Periodic Paralysis

Pinki Munot

Great Ormond Street Hospital, 
London, ENG, GB 
Experienced in Hyperkalemic Periodic Paralysis
Great Ormond Street Hospital, 
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Pinki Munot practices in London, United Kingdom. Munot is rated as an Experienced expert by MediFind in the treatment of Hyperkalemic Periodic Paralysis. Their top areas of expertise are Familial Periodic Paralysis, Hypokalemic Periodic Paralysis, Primary Lateral Sclerosis, and Spinal Muscular Atrophy (SMA).

Their clinical research consists of co-authoring 58 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Hyperkalemic Periodic Paralysis.

Locations

Great Ormond Street Hospital, London, ENG WC1N3JH, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy, Safety and Tolerability of Idebenone in Patients With Duchenne Muscular Dystrophy Receiving Glucocorticoid Steroids
A Phase III Double-blind, Randomized, Placebo-Controlled Study Assessing the Efficacy, Safety and Tolerability of Idebenone in Patients With Duchenne Muscular Dystrophy Receiving Glucocorticoid Steroids
Enrollment Status: Terminated
Publish Date: December 03, 2021
Intervention Type: Drug
Study Drug: Idebenone
Study Phase: Phase 3
A Phase III Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Who Completed the SIDEROS Study
A Phase III Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Who Completed the SIDEROS Study
Enrollment Status: Terminated
Publish Date: December 03, 2021
Intervention Type: Drug
Study Drug: Idebenone
Study Phase: Phase 3
View 1 Less Clinical Trial

58 Total Publications

Deciphering DST-associated disorders: biallelic variants affecting DST-b cause a congenital myopathy.
Deciphering DST-associated disorders: biallelic variants affecting DST-b cause a congenital myopathy.
Journal: Brain : a journal of neurology
Published: February 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Munot's expertise for a condition
ConditionClose
    View All 22 Advanced Conditions
    View All 37 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile